Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy

被引:30
|
作者
Wu, Katherine C. [1 ]
Wongvibulsin, Shannon [2 ,3 ]
Tao, Susumu [1 ]
Ashikaga, Hiroshi [1 ,2 ,3 ]
Stillabower, Michael [5 ]
Dickfeld, Timm M. [6 ]
Marine, Joseph E. [1 ]
Weiss, Robert G. [1 ,4 ]
Tomaselli, Gordon F. [7 ,8 ]
Zeger, Scott L. [9 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA
[5] Christiana Care Hlth Syst Inc, Newark, DE USA
[6] Univ Maryland, Med Syst, Dept Med, Baltimore, MD 21201 USA
[7] Albert Einstein Coll Med, Bronx, NY USA
[8] Montefiore Med, Bronx, NY USA
[9] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2020年 / 9卷 / 20期
基金
美国国家卫生研究院;
关键词
cardiac magnetic resonance imaging; heart failure; risk stratification; sudden cardiac death; ventricular arrhythmia; VENTRICULAR EJECTION FRACTION; SUDDEN CARDIAC DEATH; HEART-FAILURE; MAGNETIC-RESONANCE; MYOCARDIAL RECOVERY; SURVIVAL; ARRHYTHMIAS; MADIT; IDENTIFY; PATIENT;
D O I
10.1161/JAHA.120.017002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Current approaches fail to separate patients at high versus low risk for ventricular arrhythmias owing to overreliance on a snapshot left ventricular ejection fraction measure. We used statistical machine learning to identify important cardiac imaging and time-varying risk predictors. Methods and Results Three hundred eighty-two cardiomyopathy patients (left ventricular ejection fraction <= 35%) underwent cardiac magnetic resonance before primary prevention implantable cardioverter defibrillator insertion. The primary end point was appropriate implantable cardioverter defibrillator discharge or sudden death. Patient characteristics; serum biomarkers of inflammation, neurohormonal status, and injury; and cardiac magnetic resonance-measured left ventricle and left atrial indices and myocardial scar burden were assessed at baseline. Time-varying covariates comprised interval heart failure hospitalizations and left ventricular ejection fractions. A random forest statistical method for survival, longitudinal, and multivariable outcomes incorporating baseline and time-varying variables was compared with (1) Seattle Heart Failure model scores and (2) random forest survival and Cox regression models incorporating baseline characteristics with and without imaging variables. Age averaged 57 +/- 13 years with 28% women, 66% white, 51% ischemic, and follow-up time of 5.9 +/- 2.3 years. The primary end point (n=75) occurred at 3.3 +/- 2.4 years. Random forest statistical method for survival, longitudinal, and multivariable outcomes with baseline and time-varying predictors had the highest area under the receiver operating curve, median 0.88 (95% CI, 0.75-0.96). Top predictors comprised heart failure hospitalization, left ventricle scar, left ventricle and left atrial volumes, left atrial function, and interleukin-6 level; heart failure accounted for 67% of the variation explained by the prediction, imaging 27%, and interleukin-6 2%. Serial left ventricular ejection fraction was not a significant predictor. Conclusions Hospitalization for heart failure and baseline cardiac metrics substantially improve ventricular arrhythmic risk prediction.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Predictors of Fracture Risk of a Small Caliber Implantable Cardioverter Defibrillator Lead
    Ha, Andrew C. T.
    Vezi, Brian Z.
    Keren, Arieh
    Alanazi, Haitham
    Gollob, Michael H.
    Green, Martin S.
    Lemery, Robert
    Nery, Pablo B.
    Posan, Emoke
    Birnie, David H.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2010, 33 (04): : 437 - 443
  • [32] Prolonged QT dispersion correlates with appropriate implantable cardioverter-defibrillator therapy
    Narula, DD
    Wali, AU
    Vloka, ME
    Menon, V
    Steinberg, JS
    CIRCULATION, 1997, 96 (08) : 4008 - 4008
  • [33] Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy
    Desai, AD
    Burke, MC
    Hong, TE
    Kim, S
    Salem, Y
    Yong, PG
    Knight, BP
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2006, 17 (05) : 486 - 490
  • [34] Appropriate use of the implantable cardioverter defibrillator: A Canadian perspective
    Yee, R
    Connolly, SJ
    Gillis, AM
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1999, 22 (01): : 1 - 4
  • [35] What risk should justify implantable cardioverter defibrillator therapy?
    Schläpfer, J
    Kappenberger, L
    Fromer, M
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (5B): : 101D - 103D
  • [36] Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
    Nault, Michael A.
    McIntyre, William F.
    Simpson, Christopher S.
    Redfearn, Damian P.
    Abdollah, Hoshiar
    Brennan, F. James
    Baranchuk, Adrian
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2010, 15 (02) : 181 - 183
  • [37] Incidence of Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Heart Failure Treated With Combined Cardiac Resynchronization Plus Implantable Cardioverter-Defibrillator Therapy Versus Implantable Cardioverter-Defibrillator Therapy
    Desai, Harit
    Aronow, Wilbert S.
    Ahn, Chul
    Tsai, Fausan S.
    Lai, Hoang M.
    Gandhi, Kaushang
    Amin, Harshad
    Frishman, William H.
    Kalapatapu, Kumar
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 37 - 40
  • [38] Implantable cardioverter defibrillator therapy in athletes
    Heidbuechel, Hein
    CARDIOLOGY CLINICS, 2007, 25 (03) : 467 - +
  • [39] Implantable Cardioverter Defibrillator Therapy and Mortality
    Brown, Mark L.
    Johnson, James
    DeGroot, Paul
    Olson, Walter
    CIRCULATION, 2013, 128 (22)
  • [40] Advances in implantable cardioverter defibrillator therapy
    Rickard, John
    Wilkoff, Bruce L.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (03) : 291 - 299